Modern trade gets quick commerce check as users pivot online; grocery chains’ volume growth falls to 4% in July-Aug

Not just kiranas, but quick commerce is beginning to hurt organised grocery retailers in urban centres as consumers seek instant gratification and convenience.

While DMart, a popular grocery chain, admitted last week that online formats were hurting sales in metro stores, NielsenIQ data sourced from the industry corroborates this trend.

Sales volume growth in modern trade in July-August has decelerated to around 4% versus 24% in the corresponding two-month period a year ago, according to industry executives quoting NielsenIQ data. Sales numbers for the month of September 2024 are not out yet.

Also Read Shoppers in US and India embracing hybrid approach – Report indicate shifting trends across e-commerce Amazon, Flipkart leverage tech to drive festive sales Retailers live on hope for a late festive season push Info Edge founder Sanjeev Bikhchandani on the future of Zomato and the investment scene in India

Traditional trade, meanwhile, saw volume growth of around 5% in July-August versus 8% seen a year ago, sources said. September numbers, say sources, are not expected to dramatically alter the picture for both modern trade and traditional trade, in part due to a high base effect in the year-ago period. In July-September 2023, traditional trade and modern trade saw volume growth of 7.5% and 19.5%, respectively, according to NielsenIQ data.

While modern trade contributes around 12-15% to FMCG sales, traditional trade contributes 80% and e-commerce, which includes quick commerce, contributes 5-8%.

From under a fifth two years ago, q-commerce share within e-commerce is now over a third for FMCG companies, according to firms as well as industry experts.

Also ReadKotak Mahindra Bank reports 5% rise in standalone net profit

“Definitely, we are seeing modern retailers feel the pressure of online channels. Urban consumers want convenience and when a channel such as q-commerce is offering you just that, a pivot is likely,” Krishnarao Buddha, senior category head at Parle Products, said. The company has been pushing small, medium and large packs of all its products into q-commerce to take advantage of the boom.

In its recent earnings update for the September quarter, Dabur said it was seeing disproportionately higher growth in quick commerce. The company, therefore, had taken the strategic decision to correct distributor inventory in general trade, its largest channel,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth